Related Experiment Video
Updated: Jan 8, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities
Gabi Barmettler1,2, Saskia Leonard1, Andreas Giannakou1,3
1Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Sexual and gender minority (SGM) patients and cisgender heterosexual women (CHW) with breast cancer had similar outcomes. However, SGM patients were less likely to opt for breast conservation or reconstruction after mastectomy.
Area of Science:
- Oncology
- Health Disparities
- Surgical Oncology
Background:
- Investigating disparities in breast cancer care for sexual and gender minority (SGM) patients compared to cisgender heterosexual women (CHW).
- Understanding differences in presentation, management, and outcomes is crucial for equitable cancer care.
Purpose of the Study:
- To compare breast cancer presentation, management, and outcomes between SGM patients and CHW.
- To identify potential disparities in surgical treatment and reconstructive options.
Main Methods:
- Prospective review of an institutional database for patients with stage 0-III breast cancer (2016-2023).
- Identification of SGM patients based on self-documented sexual orientation and gender identity.
- Descriptive statistics used for comparative analysis between SGM and CHW groups.
Main Results:
- No significant differences in presenting symptoms, stage, grade, or subtype between SGM and CHW.
- SGM patients were younger at diagnosis (p=0.03) and more likely to undergo mastectomy (p=0.04).
- SGM patients were less likely to have reconstruction after mastectomy (p<0.01), with similar rates of adjuvant therapy and recurrence.
Conclusions:
- Breast cancer presentation, treatment, and outcomes were comparable between SGM and CHW patients.
- SGM patients showed a lower utilization of breast conservation and post-mastectomy reconstruction.
- Patient preference, influenced by SGM identity, may impact local therapy choices.
Related Concept Videos
Disorders of the Female Reproductive System
Treatment Resistant Cancers
Cancer Survival Analysis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Sexually Transmitted Infections

